Search

Landmark EMPA-KIDNEY trial showed significant benefit of empagliflozin in reducing kidney disease progression or cardiovascular death by 28% vs. placebo in people with chronic kidney disease

EMPA-KIDNEY Phase III clinical trial met its primary endpoint by demonstrating a significant kidney and cardiovascular benefit for adults living with chronic kidney disease

Empagliflozin Phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy

Empagliflozin Phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease

Chronic kidney disease in cats

Introducing Karl and Klara Kidney

Kidney disease and type 2 diabetes are closely linked, and share many of the same risk factors and pathological pathways

COVID-19 Q&A for people with chronic respiratory conditions

Lung Diseases

Metabolic Diseases

New approaches in the battle against heartworm disease

Heartworm disease is a concern to dog and cat owners worldwide. Current disease control methods are increasingly challenged by drug resistance. We explore the potential for novel treatments and vaccines based on new knowledge and technology.

Boehringer Ingelheim Breaks Guinness World Records™ title In Solidarity with Rare Disease

Boehringer Ingelheim Breaks Guinness World Records™ title In Solidarity with Rare Disease Patients Around the World

Boehringer Ingelheim Builds on 100 Years of Expertise To Continue Raising Awareness of Respiratory

Boehringer Ingelheim Builds on 100 Years of Expertise To Continue Raising Awareness of Respiratory Diseases

Respiratory Diseases

We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in respiratory diseases.

Boehringer Ingelheim Empowers 380 Regional Experts with Latest Insights in Cardio-Renal-Metabolic Care

Boehringer Ingelheim hosted the ‘CRM 360 standalone meeting’, ‘IMETA CRM Discussions for EXperts (MEDEX)’, to discuss the latest advances in the management of cardio-renal-metabolic conditions

Finding the right inhaler for you

Living with a chronic respiratory disease can make life complicated. This discussion guide can be used to help start a conversation with a healthcare professional about inhaler choice.

Stargardt Disease

Stargardt Disease is a hereditary condition causing and progressive vision loss, typically during childhood or adolescence.

Quick response in fighting Foot-and-Mouth-Disease

Helping to contain an outbreak of the disease on the island of Rodrigues in just six days.

Cardiometabolic Diseases

We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in CardioMetabolic diseases.

Rare Diseases: Rare but not alone

We are committed to listen and learn from patients with rare diseases to deliver breakthrough therapies.

Local healthcare community raise alarm bells on growing trend of cardiovascular disease risk

Local healthcare community raise alarm bells on growing trend of cardiovascular disease risk factors associated with type 2 diabetes

Boehringer Ingelheim Saudi Arabia Hosts Virtual Summit on the Latest Updates in Diabetes, Cardio

Boehringer Ingelheim Saudi Arabia Hosts Virtual Summit on the Latest Updates in Diabetes, Cardio-Metabolism, Respiratory Diseases and Stroke Management

Central Nervous System Diseases

Find out more about our research and development in central nervous system diseases

Skin Diseases

Heart Diseases

Partnering in Central Nervous System Diseases

We are looking for new early-science collaborations. Join our expanding community of innovation partners in central nervous system diseases.

Mareks Disease Poultry Chicken

Five things you need to know to keep poultry free from outcomes of one of the most common virus affecting the animals’ immune systems.

Diabetes dog symptoms chronic disease management

Learn about the symptoms of canine diabetes and how to manage the disease.

About Us

Human Health

Animal Health

Science & Innovation

Partnering